title: In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification.
abstract: Small ubiquitin-like modifier (SUMO) is conjugated to its substrates via an enzymatic cascade consisting of three enzymes, E1, E2, and E3. The active site of the E2 enzyme, Ubc9, recognizes the substrate through binding to a consensus tetrapeptide PsiKXE. However, recent proteomics studies suggested that a considerable part of sumoylation occurs on non-consensus sites. Current unbiased sumoylation site identification techniques typically require high stoichiometry in vitro sumoylation, mass spectrometry, and complex data analysis. To facilitate in vivo analysis, we have designed a mass spectrometric method based on an engineered human SUMO-1 construct that creates a signature tag on SUMO substrates. This construct enables affinity purification by covalent binding to cysteine residues in LysC/trypsin-cleaved peptides and site identification by diglycyl lysine tagging of sumoylation sites. As a proof of concept, site-specific and substrate-unbiased in vivo sumoylation analysis of HeLa cells was performed. We identified 14 sumoylation sites, including well known sites, such as Lys(524) of RanGAP1, and novel non-consensus sites. Only 3 of the 14 sites matched consensus sites, supporting the emerging view that non-consensus sumoylation is a common event in live cells. Six of the non-consensus sites had a nearby SUMO interaction motif (SIM), which emphasizes the role of SIM in non-consensus sumoylation. Nevertheless, the lack of nearby SIM residues among the remaining non-consensus sites indicates that there are also other specificity determinants of non-consensus sumoylation. The method we have developed proved to be a useful tool for sumoylation studies and will facilitate identification of novel SUMO substrates containing both consensus and non-consensus sites.
authors.affiliation: From the Department of Biosciences, Abo Akademi University, FI-20520 Turku, Finland.
authors.forename: Henri A
authors.initials: HA
authors.lastname: Blomster
authors.forename: Susumu Y
authors.initials: SY
authors.lastname: Imanishi
authors.forename: Jenny
authors.initials: J
authors.lastname: Siimes
authors.forename: Juha
authors.initials: J
authors.lastname: Kastu
authors.forename: Nick A
authors.initials: NA
authors.lastname: Morrice
authors.forename: John E
authors.initials: JE
authors.lastname: Eriksson
authors.forename: Lea
authors.initials: L
authors.lastname: Sistonen
mesh_terms: D020816:Amino Acid Motifs; D002853:Chromatography, Liquid / Q000379:methods; D003545:Cysteine / Q000737:chemistry*; D006367:HeLa Cells; D006801:Humans; D008239:Lysine / Q000737:chemistry; D013058:Mass Spectrometry / Q000379:methods; D010455:Peptides / Q000737:chemistry; D011499:Protein Processing, Post-Translational; D011506:Proteins / Q000737:chemistry; D020543:Proteome; D040901:Proteomics / Q000379:methods*; D025841:Small Ubiquitin-Related Modifier Proteins / Q000737:chemistry / Q000302:isolation & purification*; D014357:Trypsin / Q000737:chemistry; D025801:Ubiquitin / Q000737:chemistry
chemical_list: D010455:Peptides; D011506:Proteins; D020543:Proteome; D025841:Small Ubiquitin-Related Modifier Proteins; D025801:Ubiquitin; D014357:Trypsin; D008239:Lysine; D003545:Cysteine
references.citation: FASEB J. 2009 Nov;23(11):3978-89
references.pmid: 19622798
references.citation: Mol Cell Proteomics. 2005 Oct;4(10):1626-36
references.pmid: 16020427
references.citation: EMBO J. 2009 Nov 18;28(22):3534-48
references.pmid: 19779455
references.citation: Anal Chem. 2005 Oct 1;77(19):6310-9
references.pmid: 16194093
references.citation: J Biol Chem. 2007 Apr 6;282(14):10190-202
references.pmid: 17298944
references.citation: Anal Chem. 2001 Aug 1;73(15):3576-82
references.pmid: 11510821
references.citation: Anal Chem. 2004 Sep 15;76(18):5345-53
references.pmid: 15362891
references.citation: Mol Cell Proteomics. 2006 Oct;5(10):1899-913
references.pmid: 16684767
references.citation: Mol Cell Proteomics. 2009 Dec;8(12):2664-75
references.pmid: 19721078
references.citation: Nat Rev Mol Cell Biol. 2007 Dec;8(12):947-56
references.pmid: 18000527
references.citation: J Biol Chem. 2008 Oct 24;283(43):29405-15
references.pmid: 18708356
references.citation: Sci Signal. 2009 May 26;2(72):ra24
references.pmid: 19471022
references.citation: Nat Methods. 2006 Jul;3(7):533-9
references.pmid: 16791211
references.citation: Mol Cell Proteomics. 2009 Jun;8(6):1382-90
references.pmid: 19240082
references.citation: Mol Cell Proteomics. 2007 Aug;6(8):1380-91
references.pmid: 17510049
references.citation: Mol Cell Proteomics. 2008 Jan;7(1):132-44
references.pmid: 17938407
references.citation: Nat Rev Mol Cell Biol. 2006 Jun;7(6):391-403
references.pmid: 16723975
references.citation: J Proteome Res. 2006 Apr;5(4):988-94
references.pmid: 16602707
references.citation: Mol Cell Proteomics. 2007 Jun;6(6):1103-9
references.pmid: 17322306
references.citation: Mol Cell Proteomics. 2008 Apr;7(4):661-71
references.pmid: 18039691
references.citation: Cell. 2002 Feb 8;108(3):345-56
references.pmid: 11853669
references.citation: Proteomics. 2009 Feb;9(4):922-34
references.pmid: 19180541
references.citation: J Cell Biol. 1998 Jan 26;140(2):259-70
references.pmid: 9442102
references.citation: Nat Biotechnol. 2003 Aug;21(8):921-6
references.pmid: 12872131
references.citation: Mol Cell. 2009 Jan 16;33(1):124-35
references.pmid: 19150434
references.citation: J Biol Chem. 2001 Sep 21;276(38):35368-74
references.pmid: 11451954
references.citation: Mol Cell Proteomics. 2005 Jul;4(7):873-86
references.pmid: 15858219
references.citation: Anal Chem. 2003 Feb 1;75(3):663-70
references.pmid: 12585499